Revenue: As of FY2025 Q3, the actual value is USD 42.85 M.EPS: As of FY2025 Q3, the actual value is USD -0.01.EBIT: As of FY2025 Q3, the actual value is USD -8.319 M.<h3>Segment Revenue</h3><ul><li>Product Revenue: $14,092 for the nine months ended September 30, 2025, compared to $4,789 for the same period in 2024, representing a 194% increase.</li><li>Subscription Revenue: $62,122 for the nine months ended September 30, 2025, compared to $47,783 for the same period in 2024, representing a 30% increase.</li><li>Service Revenue: $21,224 for the nine months ended September 30, 2025, compared to $16,903 for the same period in 2024, representing a 26% increase.</li><li>License Fee and Other Revenue: $9,963 for the nine months ended September 30, 2025, compared to $5,290 for the same period in 2024, representing an 88% increase.</li></ul><h3>Operational Metrics</h3><ul><li>Gross Profit: $56,674 for the nine months ended September 30, 2025, compared to $42,721 for the same period in 2024, representing a 33% increase.</li><li>Loss from Operations: - $40,478 for the nine months ended September 30, 2025, compared to - $63,429 for the same period in 2024, representing a 36% improvement.</li><li>Net Loss: - $44,020 for the nine months ended September 30, 2025, compared to - $38,297 for the same period in 2024, representing a 15% increase.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Provided by Operating Activities: $3,098 for the nine months ended September 30, 2025, compared to - $34,057 for the same period in 2024.</li><li>Net Cash Used in Investing Activities: - $43,226 for the nine months ended September 30, 2025, compared to $11,852 for the same period in 2024.</li><li>Net Cash Provided by Financing Activities: $34,722 for the nine months ended September 30, 2025, compared to $1,151 for the same period in 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company expects its cash, cash equivalents, and marketable securities of $56.2 million as of September 30, 2025, together with cash it expects to generate from future operations and borrowing availability under the Senior Secured Credit Facilities, will be sufficient to fund its operating expenses and capital expenditure requirements for a period of at least twelve months from the date of this Quarterly Report on Form 10-Q.</li><li>Non-Core Business: The company has entered into a non-exclusive contract manufacturing agreement with Plexus Corp. to enhance scalability, geographic diversification, and operational resiliency.</li></ul>

Evolv Tech Holdings - CW25 | 10-Q: FY2025 Q3 Revenue: USD 42.85 M